Older patients with cancer and febrile neutropenia in the COVID-19 era: A new concern

J Geriatr Oncol. 2020 Nov;11(8):1329-1330. doi: 10.1016/j.jgo.2020.06.021. Epub 2020 Jun 18.

Authors

Antonino C Tralongo¹, Martine Extermann²

Affiliations

¹ Senior Adult Oncology Program, Moffitt Cancer Center, Tampa, FL, USA; Medical Oncology, Ospedale di Circolo e Fondazione Macchi, Varese, University of Pavia, Italy. Electronic address: a.c.tralongo@gmail.com.
² Senior Adult Oncology Program, Moffitt Cancer Center, Tampa, FL, USA.

No abstract available

Publication types

Letter

MeSH terms

Aged
COVID-19 / complications*
COVID-19 / epidemiology
Febrile Neutropenia / complications*
Febrile Neutropenia / drug therapy*
Febrile Neutropenia / virology
Granulocyte Colony-Stimulating Factor / adverse effects*
Granulocyte Colony-Stimulating Factor / pharmacology
Granulocyte Colony-Stimulating Factor / therapeutic use
Humans
Neoplasms / complications*
Neoplasms / drug therapy
Neoplasms / therapy
Pandemics
Risk Factors
SARS-CoV-2 / immunology

Substances

Granulocyte Colony-Stimulating Factor